SCHEMBL29519982

SCHEMBL29519982

c1ccc2c(c1)[nH]c1cc3c(cc12)oc1ccccc13

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.64
CYP1A2 P05177 1/20 0.53
ALDH1A1 P00352 3/20 0.50
GPR3 P46089 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KIF11 P52732 10/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TOP2A P11388 1/20 0.44
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1635861 1.00 AHR (0.64) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL29890056 1.00 AHR (0.64) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL29986934 0.93 CYP1A2 (0.60) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL29819907 0.93 CYP1A2 (0.60) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL14822627 0.93 CYP1A2 (0.60) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL16999816 0.91 CYP1A2 (0.59) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL17381086 0.89 AHR (0.64) AHRCYP1A2ALDH1A1GPR3HSD17B10
Carbazole SCHEMBL29283447 0.87 ALDH1A1 (0.67) AHRCYP1A2ALDH1A1GPR3HSD17B10
Carbazole SCHEMBL7765601 0.87 ALDH1A1 (0.67) AHRCYP1A2ALDH1A1GPR3HSD17B10
SCHEMBL19831840 0.86 CYP1A2 (0.50) AHRCYP1A2ALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110884-B1 USE OF HETEROCYCLIC COMPOUNDS IN AN ORGANIC ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2024-11-20 EP disclosed
CN-114464744-B Composition for organic photoelectric device, organic photoelectric device and display device 三星SDI株式会社 2024-10-29 CN disclosed
US-20240357926-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2024-10-24 US disclosed
EP-3538623-B1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-12-20 EP disclosed
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
EP-4271163-A2 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP Merck Patent GmbH (DE) 2023-11-01 EP disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
EP-3898888-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-08-03 EP disclosed
US-20220149295-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-05-12 US disclosed
CN-114464744-A Composition for organic photoelectric device, and display device 三星SDI株式会社 2022-05-10 CN disclosed
US-11309497-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2022-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240357926-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, L1CAM, EPCAM AHR 3241/4885CYP1A2 1427/4885ALDH1A1 441/4885
US-20220149295-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OCIAD2, OR10J3, OCIAD1 AHR 2176/4885CYP1A2 428/4885ALDH1A1 223/4885
US-11711976-B2 Compounds with an acceptor and a donor group NQO1, ICMT, NUDT1 AHR 1578/4885CYP1A2 394/4885ALDH1A1 242/4885
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 AHR 1578/4885CYP1A2 394/4885ALDH1A1 242/4885
US-11309497-B2 Materials for organic electroluminescent devices DDT, ESD, TST AHR 2625/4885CYP1A2 2369/4885ALDH1A1 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.